Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
46 hedge funds and large institutions have $121M invested in Akoya BioSciences in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 5 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
2% more funds holding
Funds holding: 45 → 46 (+1)
0.23% more ownership
Funds ownership: 32.62% → 32.85% (+0.23%)
29% less capital invested
Capital invested by funds: $169M → $121M (-$48.4M)
97% less call options, than puts
Call options by funds: $13K | Put options by funds: $396K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
+$4.38M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.26M |
| 3 |
Millennium Management
New York
|
+$1.07M |
| 4 |
HEC
Hudson Executive Capital
New York
|
+$525K |
| 5 |
State Street
Boston,
Massachusetts
|
+$315K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$6.12M |
| 2 |
Two Sigma Investments
New York
|
-$938K |
| 3 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$611K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$313K |
| 5 |
RI
RTW Investments
New York
|
-$259K |
AKYA Hedge Fund Activity: Q1 2022 in Review
46 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q1 2022, worth a combined $121M — down 29% from $169M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AKYA positions and 5 closed out — a net gain of 1 holder — while 19 added to existing stakes and 15 trimmed.
The largest buyer was Blue Water Life Science Advisors, adding an estimated $4.38M. The largest seller was VR Adviser, exiting entirely with an estimated $6.12M sold.
- 46 institutional investors held Akoya BioSciences (AKYA) as of Q1 2022, up from 45 in Q4 2021.
- Funds reported $121M of Akoya BioSciences stock for Q1 2022, down 29% quarter-over-quarter.
- 6 funds opened new Akoya BioSciences positions in Q1 2022 and 5 closed out, a net change of +1 holder.
- The largest Akoya BioSciences buyer in Q1 2022 was Blue Water Life Science Advisors, an estimated $4.38M added.
- The largest Akoya BioSciences seller in Q1 2022 was VR Adviser, an estimated $6.12M sold.
Based on aggregated 13F filings for Q1 2022.